Skip to content

Patient preference for colorectal cancer surveillance strategy in inflammatory bowel disease: a discrete choice experiment

Patient preference for colorectal cancer surveillance strategy in inflammatory bowel disease: a discrete choice experiment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29540
Enrollment
400
Registered
2020-01-17
Start date
2020-01-17
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease, IBD, Crohn's disease, ulcerative colitis

Interventions

Patients will be asked to fill in our questionnaire once

Sponsors

UMC Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Diagnosis of IBD (Crohn’s disease, ulcerative colitis, IBD-unclassified) - Age = 18 years - Signed informed consent - Fulfilling criteria to undergo surveillance colonoscopy according to the Dutch IBD guidelines

Exclusion criteria

Exclusion criteria: Potential subjects who meet any of the following criteria will be excluded from participation from this study: - No signed informed consent - Insufficient knowledge of the Dutch language or illiteracy to independently complete the questionnaire

Design outcomes

Primary

MeasureTime frame
1.To determine patients’ preferences with respect to colonoscopic surveillance intervals.

Secondary

MeasureTime frame
1. To assess the relative importance of disease-related and psychosocial factors, driving the patients’ preferences on CRC surveillance intensity. 2. To compare the preferred surveillance intervals between IBD patients treated in a non-academic hospital or in an academic hospital. 3. To identify differences in preference structures among subgroups in the IBD cohort (e.g. disease duration, positive versus negative family history of CRC)

Contacts

Public ContactAnouk Wijnands

UMC Utrecht

A.M.Wijnands-3@umcutrecht.nl+31 88 75 50878.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)